Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2701-2704

  Morath, Christian ^a   Sis, Jeanne ^a   Haensch, Gertrud M ^a   Zeier, Martin ^a   Andrassy, Konrad ^a   Schwenger, Vedat ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Goodpasture's syndrome; Infection; Inflammation; Procalcitonin

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CEFOTAXIME; CYCLOPHOSPHAMIDE; DOXYCYCLINE; FLUCONAZOLE; FRESH FROZEN PLASMA; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLUCOCORTICOID; IMIPENEM; LEVOFLOXACIN; METHYLPREDNISOLONE; PIPERACILLIN; PROCALCITONIN; TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DISEASE SEVERITY; DRUG MEGADOSE; DRUG PULSE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HORMONE BLOOD LEVEL; HUMAN; INFECTION; KIDNEY BIOPSY; KIDNEY FAILURE; LUNG DISEASE; MALE; MEDICAL RECORD REVIEW; NEPHELOMETRY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COMMUNICABLE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; TIME FACTORS;

EID: 34548448588     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm353     Document Type: Article

References (12)

1. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport. N Engl J Med 2003; 348: 2543-2556
2. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-217
3. Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998; 26: 274-276
4. Conti G, Amore A, Chiesa M et al. Procalcitonin as a marker of micro-inflammation in hemodialysis. J Nephrol 2005; 18: 282-288
5. Adam B, Calikoglu E. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behcet's disease. J Eur Acad Dermatol Venereol 2004; 18: 318-320
6. Okada Y, Minakami H, Tomomasa T et al. Serum procalcitonin concentration in patients with Kawasaki disease. J Infect 2004; 48: 199-205
7. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol 1998; 25: 1531-1533
8. Borchhardt KA, Horl WH, Sunder-Plassmann G. Reversibility of secondary hypercalcitoninemia after kidney transplantation. Am J Transplant 2005; 5: 1757-1763
9. Steinbach G, Bolke E, Grunert A, Storck M, Orth K. Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 2004; 116: 849-853
10. Becker KL, Nylen ES, White JC, Muller B, Snider RH, Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512-1525
11. Morgenthaler NG, Struck J, Chancerelle Y et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res 2003; 35: 290-295
12. Nylen ES, O'Neill W, Jordan MH et al. Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 1992; 24: 439-443